Yesterday the FDA licensed ocrelizumab for people with PPMS

Everyday living
1

" Yesterday was a pretty momentous day for people with MS (pwMS). The FDA licensed ocrelizumab for people with PPMS." Barts MS Blog.

http://multiple-sclerosis-research.blogspot.com/2017/03/newsspeak-eagle-called-ocrelizumab-has.html#comment-form

1 Like
2

Ditto!

Polls

3

Will it be prescribed for people with SPMS?

Looking to the future not much, if any, difference between SPMS and PPMS

4

I have PPMS what will it mean for me ? What happens next ?

5

I took this from the MS Trust site.

“Ocrelizumab is currently being assessed for drug licensing by the EMA (European Medicines Agency) for both relapsing remitting and primary progressive MS. It will then be appraised for cost and effectiveness as an NHS treatment for both types of MS. If these steps are successful ocrelizumab could be available on the NHS by 2018 at the earliest. The FDA decision does not affect the European assessment.”

2 Likes
6

No, it’s licenced for PPMS and RRMS - I think Siponimod is next up for SPMS

(I agree about progression being progression, but it’s still being treated differently for now)

7

Apparently this new product retails for less cost than Rebif! (Stateside at least)

8

Yep, $65,000 annually apparently. Interesting reading no 1:

Multiple Sclerosis Research: #NewsSpeak: an eagle called ocrelizumab has landed had lots of comments when I looked this morning

But I would check this out before we get too excited:

And the preceding articles on WK’s blog about Ocrevus

Not being negative, btw, just think we should be making informed decisions - do your own research and all that.

Jo x

1 Like